Evaluation of Cost-Effective Therapy by Comparing Brands of the Same Formulation in Pakistan
Abstract
Abstract Views: 385
In Pakistan, where millions face the burden of healthcare costs, the choice between branded and alternative drug formulations plays a crucial role in patient outcomes. Often, branded medications are prescribed over more cost-effective options, exacerbating financial strain for patients, especially in low- and middle-income settings. The current study is crucial to address healthcare affordability, highlighting significant cost disparities between prescribed branded medications and alternatives. It critically aimed to evaluate cost-effective therapies by comparing prescribed brands with other options for cardiovascular diseases (CVDs), diabetes, neurological disorders, and paediatrics. Furthermore, the study also identified the cost-effective therapies for CVDs, diabetes, neurological disorders, and pediatric conditions between branded medications with their generic and alternative counterparts in Pakistan. This would help to achieve cost-effective therapies. Additionally, it also shed light on the hurdles faced by the regulators to impose generic prescribing across Pakistan. It may motivate healthcare providers and policymakers about the benefits of generic prescribing to provide cost-effective treatment plan which may lead towards the overall patients’ satisfaction. Data collected from various regions of Pakistan across public and private healthcare sectors revealed significant cost disparities between branded and alternative medications. The analysis conducted in the study indicated a potential cost reduction of up to 66% for CVDs, 47% for neurological disorders, and 21% and 43% for diabetes and paediatrics, respectively, by opting for alternative brands. These findings underscore the urgent need for policy reforms, promoting generic prescriptions and leveraging pharmacists' expertise to enhance affordability and accessibility in the Pakistani healthcare system.
Downloads
References
Hassali MA, Shafie AA, Jamshed S, Ibrahim MI, Awaisu A. Consumers' views on generic medicines: a review of the literature. Int J Pharm Pract. 2009;17(2):79–88. https://doi.org/10.1211/ijpp.17.02.0002
Girardin FR, Cohen K, Schwenkglenks M, Durand-Zaleski I. Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment. Front Pharmacol. 2023;14:e1210002. https://doi.org/10.3389/fphar.2023.1210002
Atif M, Azeem M, Sarwar MR. Potential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literature. Springerplus. 2016;5:1–8. https://doi.org/10.1186/s40064-016-1824-2
World Health Organization. Progress in Essential Drugs and Medicines Policy: 1998–1999. World Health Organization; 2000.
World Health Organization. Cardiovascular diseases (CVDs). WHO Web site. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed May 20, 2024.
Rattani SA. Case Study Describing Access to Palliative Care in Pakistan [doctoral thesis]. Pakistan: Aga Khan University; 2020.
Jafar TH, Haaland BA, Rahman A, et al. Non-communicable diseases and injuries in Pakistan: strategic priorities. Lancet. 2013;381(9885):2281–2290. https://doi.org/10.1016/S0140-6736(13)60646-7
Lozano R, Naghavi M, Foreman K, Lim S. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128. https://doi.org/10.1016/S0140-6736(12)61728-0
Wood L. A review on adherence management in patients on oral cancer therapies. Eur J Oncol Nurs. 2012;16(4):432–438. https://doi.org/10.1016/j.ejon.2011.10.002
GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459–480. https://doi.org/10.1016/S1474-4422(18)30499-X
Premnath K, Arunprasath K, Sanjeevi R, Elilvanan R, Ramesh M. Natural/synthetic fiber reinforced hybrid composites on their mechanical behaviors–a review. Interactions. 2024;245(1):e111. https://doi.org/10.1007/s10751-024-01924-y
Reichert T. The prevalence of sexual imagery in ads targeted to young adults. J Consum Aff. 2003;37(2):403–412. https://doi.org/10.1111/j.1745-6606.2003.tb00460.x
Reichert S, Simon T, Halm EA. Physicians' attitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med. 2000;160(18):2799–2803. https://doi.org/10.1001/archinte.160.18.2799
Zarei E, Ghaffari A, Nikoobar A, Bastami S, Hamdghaddari H. Interaction between physicians and the pharmaceutical industry: a scoping review for developing a policy brief. Front Public Health. 2023;10:e1072708. https://doi.org/10.3389/fpubh.2022.1072708
Premanath M, Kulkarni P. Generic drugs or branded generics, which one you prefer to prescribe? APIK J Intern Med. 2024;12(3):195–196. https://doi.org/10.4103/ajim.ajim_119_23
Chrystyn H, Price D. Not all asthma inhalers are the same: factors to consider when prescribing an inhaler. Prim Care Respir J. 2009;18(4):243–249. https://doi.org/10.4104/pcrj.2009.00029
Yu LX. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res. 2008;25:781–791. https://doi.org/10.1007/s11095-007-9511-1
Vallès JA, Barreiro M, Cereza G, et al. Acceptance of generic prescribing in general practice: effect of patient education and reference prices. Gac Sanit. 2002;16(6):505–510. https://doi.org/10.1016/s0213-9111(02)71972-9
Copyright (c) 2024 Nayab Sajid, Abdul Aziz, Samia Asif, Saba Ashraf, Azeem Ahmed Iqbal, Gohar Ali, Muhammed Amir, Junaid Ikram
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal
